KYMR
#931
Kymera Therapeutics, Inc. - Common Stock
118.1 5 USD
-0.02%
Market Price
Sector: Healthcare
Base: USD
Profit Currency: USD
Daily Range
Year Range
Daily Change
-1.73%
Monthly Change
+11.82%
6 month change
+32.40%
Year Change
+99.92%
Previous Close
120.2 3
Open
118.2 1
Low
118.1 5
High
118.2 1
Volume
147
Financials
- Market Capitalization 9.82 B
- Employee 273
- Founded 2015
- CEO N/A
- Website www.kymeratx.com
- Headquarter Delaware, United States
- FIGI BBG00SDHC8D1
- Industry Biotechnology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
-21.09
Price to sales ratio
167.66
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 918 |  CYTK Cytokinetics, Incorporated - Common Stock | 72.09 USD | -7.46% | -6.75% | -8.04% | +24.08% | 10.02 B USD | ||
| 923 |  KNSA Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares | 78.08 USD | -2.16% | -1.54% | -1.66% | +96.95% | 9.93 B USD | ||
| 940 |  PRAX Praxis Precision Medicines, Inc. - Common Stock | 344.75 USD | -6.28% | -6.79% | +15.50% | +664.41% | 9.63 B USD | ||
| 961 |  PTGX Protagonist Therapeutics, Inc. - Common Stock | 144.33 USD | -3.46% | -6.47% | +9.53% | +92.11% | 9.34 B USD |
Frequently asked questions about Kymera Therapeutics, Inc. Common Stock
What is the Kymera Therapeutics, Inc. Common Stock stock price today?
The current price of Kymera Therapeutics, Inc. Common Stock (KYMR) is 118.15. Over the past 24 hours, the stock has changed by -1.73%. Follow the KYMR chart for real-time price dynamics.
What is the stock ticker of Kymera Therapeutics, Inc. Common Stock?
Kymera Therapeutics, Inc. Common Stock trades under the ticker KYMR. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Kymera Therapeutics, Inc. Common Stock stock going up?
KYMR has changed by -0.39% over the last week, +11.82% over the last month, and +99.92% over the last year. Review the chart to see whether the current move is part of a broader trend.
What is the market capitalization of Kymera Therapeutics, Inc. Common Stock?
Kymera Therapeutics, Inc. Common Stock currently has a market capitalization of 9.82 B. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.
What were Kymera Therapeutics, Inc. Common Stock earnings last quarter?
Last quarter, Kymera Therapeutics, Inc. Common Stock reported earnings of -0.62 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.
What was Kymera Therapeutics, Inc. Common Stock revenue for the last quarter?
Kymera Therapeutics, Inc. Common Stock reported quarterly revenue of 65 M. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.
What was Kymera Therapeutics, Inc. Common Stock net income for the last quarter?
Kymera Therapeutics, Inc. Common Stock reported net income of -61.21 M for the last quarter. The previous quarter showed -69.23 M, which means net income changed by +11.59%.
How many employees does Kymera Therapeutics, Inc. Common Stock have?
As of the latest available data, Kymera Therapeutics, Inc. Common Stock has 273 employees. Workforce size can provide additional context about the company's scale and operations.
What is Kymera Therapeutics, Inc. Common Stock EBITDA?
Kymera Therapeutics, Inc. Common Stock EBITDA is -138.58 M, and its EBITDA margin is -213.2%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Kymera Therapeutics, Inc. Common Stock stock?
You can buy Kymera Therapeutics, Inc. Common Stock (KYMR) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Kymera Therapeutics, Inc. Common Stock stock?
Investing in Kymera Therapeutics, Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KYMR chart and related analysis on metatrader.com as part of your research.